Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

Marambaud P, Zhao H, Davies P.

J Biol Chem. 2005 Nov 11;280(45):37377-82. Epub 2005 Sep 14.

2.

Resveratrol, a neuroprotective supplement for Alzheimer's disease.

Li F, Gong Q, Dong H, Shi J.

Curr Pharm Des. 2012;18(1):27-33. Review.

PMID:
22211686
3.

Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.

Smid SD, Maag JL, Musgrave IF.

Food Funct. 2012 Dec;3(12):1242-50. doi: 10.1039/c2fo30075c. Review.

PMID:
22929970
4.

Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease.

Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM.

FASEB J. 2006 Nov;20(13):2313-20.

PMID:
17077308
5.

Therapeutic potential of resveratrol in Alzheimer's disease.

Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S6. doi: 10.1186/1471-2202-9-S2-S6. Review.

6.

Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.

Regitz C, Fitzenberger E, Mahn FL, Dußling LM, Wenzel U.

Eur J Nutr. 2016 Mar;55(2):741-747. doi: 10.1007/s00394-015-0894-1. Epub 2015 Apr 8.

PMID:
25851110
7.

Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicity.

Granzotto A, Zatta P.

PLoS One. 2011;6(6):e21565. doi: 10.1371/journal.pone.0021565. Epub 2011 Jun 27.

8.

Resveratrol--a boon for treating Alzheimer's disease?

Anekonda TS.

Brain Res Rev. 2006 Sep;52(2):316-26. Review.

PMID:
16766037
9.

Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity.

Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Müller-Spahn F.

Gerontology. 2003 Nov-Dec;49(6):380-3.

10.

Amyloid-β secretion, generation, and lysosomal sequestration in response to proteasome inhibition: involvement of autophagy.

Agholme L, Hallbeck M, Benedikz E, Marcusson J, Kågedal K.

J Alzheimers Dis. 2012;31(2):343-58. doi: 10.3233/JAD-2012-120001.

PMID:
22555375
11.

Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.

Regitz C, Dußling LM, Wenzel U.

Mol Nutr Food Res. 2014 Oct;58(10):1931-40. doi: 10.1002/mnfr.201400014. Epub 2014 Jul 28.

PMID:
25066301
12.

[Resveratrol: a neuroprotective polyphenol in the Mediterranean diet].

López-Miranda V, Soto-Montenegro ML, Vera G, Herradón E, Desco M, Abalo R.

Rev Neurol. 2012 Mar 16;54(6):349-56. Review. Spanish.

13.

Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.

Paris D, Beaulieu-Abdelahad D, Bachmeier C, Reed J, Ait-Ghezala G, Bishop A, Chao J, Mathura V, Crawford F, Mullan M.

Eur J Pharmacol. 2011 Nov 30;670(2-3):384-91. doi: 10.1016/j.ejphar.2011.09.019. Epub 2011 Sep 19.

PMID:
21958873
14.

Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.

Hong L, Huang HC, Jiang ZF.

Neurol Res. 2014 Mar;36(3):276-82. doi: 10.1179/1743132813Y.0000000288. Review.

PMID:
24512022
15.
16.

Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.

Li SY, Wang XB, Kong LY.

Eur J Med Chem. 2014 Jan;71:36-45. doi: 10.1016/j.ejmech.2013.10.068. Epub 2013 Nov 4.

PMID:
24269515
18.

4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.

Choi IS, Lee YJ, Choi DY, Lee YK, Lee YH, Kim KH, Kim YH, Jeon YH, Kim EH, Han SB, Jung JK, Yun YP, Oh KW, Hwang DY, Hong JT.

J Alzheimers Dis. 2011;27(1):127-41. doi: 10.3233/JAD-2011-110545.

PMID:
21799245
19.

Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.

Braidy N, Jugder BE, Poljak A, Jayasena T, Mansour H, Nabavi SM, Sachdev P, Grant R.

Curr Top Med Chem. 2016;16(17):1951-60. Review.

PMID:
26845555
20.

Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.

Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT.

J Nutr. 2009 Oct;139(10):1987-93. doi: 10.3945/jn.109.109785. Epub 2009 Aug 5.

PMID:
19656855

Supplemental Content

Support Center